Difference between revisions of "Template:General anesthetics"
Jump to navigation
Jump to search
imported>Edgar181 (bypass redirect) |
(added barbiturate category, added etomidate) |
||
Line 34: | Line 34: | ||
* [[Propofol]]<sup>#</sup> | * [[Propofol]]<sup>#</sup> | ||
− | | group2 = [[Opioid]]s | + | | group2 = [[Barbiturates]] |
− | | | + | | list2 = |
+ | *[[Hexobarbital]] | ||
+ | *[[Methohexital]] | ||
+ | *[[Narcobarbital]] | ||
+ | *[[Thiopental]]<sup>#</sup> | ||
+ | *[[Thiotetrabarbital]] | ||
+ | |||
+ | | group3 = [[Opioid]]s | ||
+ | | list3 = | ||
* [[Morphine]]<sup>#</sup> | * [[Morphine]]<sup>#</sup> | ||
* [[Oxycodone]] | * [[Oxycodone]] | ||
Line 46: | Line 54: | ||
* [[Sufentanil]] | * [[Sufentanil]] | ||
− | | | + | | group4 = [[Arylcyclohexylamine]]s |
− | | | + | | list4 = |
* [[Esketamine]] | * [[Esketamine]] | ||
* [[Ketamine]]<sup>#</sup> | * [[Ketamine]]<sup>#</sup> | ||
Line 53: | Line 61: | ||
* [[Tiletamine]] | * [[Tiletamine]] | ||
− | | | + | | group5 = [[Neuroactive steroid]]s |
− | | | + | | list5 = |
* [[Alfadolone]] | * [[Alfadolone]] | ||
* [[Alfaxalone]] | * [[Alfaxalone]] | ||
* [[Hydroxydione]] | * [[Hydroxydione]] | ||
− | | | + | | group6 = Others |
− | | | + | | list6 = |
+ | * [[Etomidate]] | ||
* [[Propanidid]]<sup>‡</sup> | * [[Propanidid]]<sup>‡</sup> | ||
Latest revision as of 20:10, 29 August 2019
Initial visibility: currently defaults to autocollapse
To set this template's initial visibility, the |state=
parameter may be used:
|state=collapsed
:{{General anesthetics|state=collapsed}}
to show the template collapsed, i.e., hidden apart from its title bar|state=expanded
:{{General anesthetics|state=expanded}}
to show the template expanded, i.e., fully visible|state=autocollapse
:{{General anesthetics|state=autocollapse}}
If the |state=
parameter in the template on this page is not set, the template's initial visibility is taken from the |default=
parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse
.